Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
salicylate
nonsteroidal anti-inflammatory drug |
| gptkbp:approvedBy |
1978
|
| gptkbp:ATCCode |
M01AB03
|
| gptkbp:CASNumber |
22494-42-4
|
| gptkbp:chemicalFormula |
C13H8F2O3
|
| gptkbp:contraindication |
hypersensitivity to NSAIDs
active peptic ulcer |
| gptkbp:discoveredBy |
gptkb:Merck_&_Co.
|
| gptkbp:eliminationHalfLife |
8-12 hours
|
| gptkbp:excretion |
urine
|
| https://www.w3.org/2000/01/rdf-schema#label |
diflunisal
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
COX inhibitor
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
250.20 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
rash gastrointestinal upset |
| gptkbp:synonym |
2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid
Dolobid |
| gptkbp:usedFor |
pain
arthritis |
| gptkbp:bfsParent |
gptkb:salicylates
|
| gptkbp:bfsLayer |
7
|